Clinical Trial Update: Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1 study evaluating the safety and immunogenicity of the rVSV-Nipah virus vaccine candidate PHV02 in hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nipah Virus Infection

Drugs mentioned

• PHV02 (rVSV-Nipah virus vaccine candidate) (PHV02)

Snippet

Sponsor: Public Health Vaccines LLC | Conditions: Nipah Virus Infection | Phase 1 | Status: COMPLETED